AXGN AxoGen, Inc.
$37.46▼ -1.47%
Healthcare
Other
After hours
$37.46▲ +0.00%
Oct 27, 5:07 PM ET
Volume 2.46M
Avg Volume (10D) 1.25M
Key Metrics & Fundamentals
Market Cap
$2.20B
P/E Ratio
–
Div Yield
0.00%
52W Range
17.14 - 52.91
% vs 50 MA
-12.48%
% vs 200 MA
-4.67%
RSI-14
43.8
MACD Histogram
+0.5400
Beta (1Y vs SPY)
0.84
Free Cash Flow
$5.47M
Gross Rev
$69.73M
Gross Profit
$50.67M
EBITDA
-$149,000
COGS
$19.06M
Operating Exp
$52.83M
Operating Income
-$2.16M
EBIT
-$2.16M
Pretax Income
-$1.52M
Net Income
-$1.52M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · Oct 21, 2026 9:00 AM ET

GMED or AXGN: Which Is the Better Value Stock Right Now?
Zacks · Oct 16, 2026 10:40 AM ET

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
GlobeNewswire · Oct 14, 2026 7:00 AM ET

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Zacks · Oct 13, 2026 12:41 PM ET
BofA Securities Initiates Axogen at Buy, $52 Price Target
MT Newswires · Oct 12, 2026 6:16 AM ET

Axogen (AXGN) Stock Could Be 26% Undervalued On Cash Flow Grounds
Simply Wall St. · Oct 9, 2026 2:08 PM ET

Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 7, 2026 10:00 AM ET
Barclays Initiates Coverage on Axogen With Overweight Rating, $55 Price Target
MT Newswires · Oct 7, 2026 8:03 AM ET
Barclays Initiates Axogen at Overweight With $55 Price Target
MT Newswires · Oct 7, 2026 8:03 AM ET

Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)
Zacks · Oct 5, 2026 8:35 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AXGN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.